Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank-check company focused on the biotechnology and life sciences sector. The SPAC completed its initial public offering in 2021 and, as reflected in its 10-Q filed with the SEC on August 12, 2022, remained in its search phase for a suitable acquisition target within the biotech space. The vehicle targets companies across therapeutics, diagnostics, and related life-sciences segments, aiming to identify a merger partner with growth potential in an increasingly competitive sector for SPAC activity. Visit SpacDesk and sign up for full data, filings history, and real-time deal tracking on ORIA and hundreds of other active SPACs.